Iqbal Zafeer-Ul-Hassan, Pervaiz Ayesha, Chaudhry Fatima, Shakeel Zunaira, Hassan Shahzaib, Faiaz Himat Ali, Aleem Shahnoor
Internal Medicine, District Headquarter Hospital, Rawalpindi, PAK.
Internal Medicine, Punjab Rangers Teaching Hospital, Lahore, PAK.
Cureus. 2025 Jul 10;17(7):e87677. doi: 10.7759/cureus.87677. eCollection 2025 Jul.
Background Hepatic encephalopathy (HE) is a serious neuropsychiatric complication of liver dysfunction associated with significant morbidity and mortality. Objective The objective of this study was to evaluate the predictors of in-hospital mortality in patients with HE through retrospective analysis. Methods This retrospective observational cohort study was conducted at Punjab Rangers Teaching Hospital, Lahore, Pakistan, from January 2023 to January 2025. A total of 201 adult patients (≥18 years) admitted with a diagnosis of hepatic encephalopathy were included in the study. The diagnosis of HE was made clinically based on the West Haven criteria and supported by biochemical and radiological assessments as needed. Patients with both acute and chronic liver disease were considered, provided they fulfilled the diagnostic criteria for HE. Data were extracted from the hospital's electronic medical record system using a structured questionnaire. Clinical and laboratory parameters were analyzed to identify predictors of in-hospital mortality using multivariate logistic regression. Results The in-hospital mortality rate was 57 (28.4%). Non-survivors had significantly higher Model for End-Stage Liver Disease (MELD) scores (mean 29.3 vs. 24.9, p < 0.001), elevated serum ammonia levels (mean 136.2 µmol/L vs. 103.1 µmol/L, p < 0.001), more frequent renal dysfunction (37 (64.9%) vs. 41 (28.9%), p < 0.001), and hyponatremia (33 (57.9%) vs. 43 (29.6%), p = 0.002). High-grade HE (Grade III/IV) was more prevalent among non-survivors (42 (73.7%) vs. 52 (36.2%), p < 0.001). Independent predictors of mortality included MELD score ≥28, serum ammonia ≥120 µmol/L, renal dysfunction, serum sodium <130 mEq/L, and high-grade HE. The MELD score demonstrated the highest discriminatory ability (area under the curve (AUC) = 0.78). Conclusion In patients with HE, higher MELD scores, elevated serum ammonia, renal impairment, hyponatremia, and advanced HE grades are significant predictors of mortality. These findings highlight the importance of early risk assessment and may guide decisions regarding intensive management and liver transplant referral.
肝性脑病(HE)是肝功能障碍的一种严重神经精神并发症,具有较高的发病率和死亡率。
本研究旨在通过回顾性分析评估肝性脑病患者院内死亡的预测因素。
本回顾性观察性队列研究于2023年1月至2025年1月在巴基斯坦拉合尔的旁遮普游骑兵教学医院进行。共有201例诊断为肝性脑病的成年患者(≥18岁)纳入研究。肝性脑病的诊断根据西黑文标准临床做出,并根据需要通过生化和放射学评估予以支持。急性和慢性肝病患者只要符合肝性脑病诊断标准均纳入研究。使用结构化问卷从医院电子病历系统中提取数据。采用多因素逻辑回归分析临床和实验室参数以确定院内死亡的预测因素。
院内死亡率为57例(28.4%)。非存活者终末期肝病模型(MELD)评分显著更高(平均29.3对24.9,p<0.001),血清氨水平升高(平均136.2µmol/L对103.1µmol/L,p<0.001),肾功能不全更常见(37例(64.9%)对41例(28.9%),p<0.001),低钠血症(33例(57.9%)对43例(29.6%),p=0.002)。高级别肝性脑病(III/IV级)在非存活者中更常见(42例(73.7%)对52例(36.2%),p<0.001)。死亡的独立预测因素包括MELD评分≥28、血清氨≥120µmol/L、肾功能不全、血清钠<130mEq/L和高级别肝性脑病。MELD评分显示出最高的鉴别能力(曲线下面积(AUC)=0.78)。
在肝性脑病患者中,较高的MELD评分、血清氨升高、肾功能损害、低钠血症和高级别肝性脑病分级是死亡的重要预测因素。这些发现凸显了早期风险评估的重要性,并可能指导有关强化管理和肝移植转诊的决策。